Short answer
Turning Point Brands, Inc. (TPB) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Third-quarter results for the three months ended September 30, 2026 announced by Turning Point Brands.
Turning Point Brands, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter results for the three months ended September 30, 2026 announced by Turning Point Brands
- Full financial details and management commentary in Exhibit 99.1 press release
Item 7.01 · Regulation FD Disclosure
- Investor presentation posted November 9, 2026 with supplemental information for quarter ended September 30, 2026
- Presentation available through Turning Point Brands’ investor relations events and presentations page
- Supplemental materials may provide additional operating and financial context beyond the quarterly filing
Item EX-99.1 · Exhibit EX-99.1
- Q3 2026 revenue $151.1M, up 27.0%, led by Modern Oral and Stoker’s growth
- Modern Oral net sales $74.4M, up 102.9%, now 49.2% of company sales
- Profitability weakened: net income $3.9M, down 81.4%, and Adjusted EBITDA $18.4M, down 41.3%
- SG&A rose 69.1% to $75.3M, reflecting sales investments, FDA PMTA costs and higher outbound freight
- FY 2026 guidance reaffirmed: Modern Oral net sales $260-$270M and Adjusted EBITDA $70-$80M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Turning Point Brands, Inc. 8-K filings
Get the next TPB 8-K as it lands
Follow TPB for push alerts, or ask the research agent what this filing means.